Literature DB >> 23906236

Diabetes mellitus, metabolic syndrome and obesity are not significant risk factors for hepatocellular carcinoma in an HBV- and HCV-endemic area of Southern Taiwan.

Chao-Tung Chen1, Jing-Yi Chen, Jing-Houng Wang, Kuo-Chin Chang, Po-Lin Tseng, Kwong-Ming Kee, Pao-Fei Chen, Lin-San Tsai, Shu-Chuan Chen, Sheng-Che Lin, Sheng-Nan Lu.   

Abstract

A prominent factor in hepatocellular carcinoma (HCC) is chronic infection with hepatitis B virus (HBV) and hepatitis C virus (HCV). Diabetes mellitus (DM), metabolic syndrome (MetS), and obesity have also been implicated in HCC development, but these associations are not observed in all HBV- and HCV-endemic areas. We attempted to clarify the role of these factors in HCC development in an HBV- and HCV-endemic area in southern Taiwan. A community-based health examination was conducted in 2004 in Tainan County. After individuals with incomplete data and those with known HCC were excluded, there were 56,231 participants who were over 40 years of age. A further 262 HCC cases were identified from the National Cancer Registration Database records from 2005 to 2007. The hepatitis B surface antigen (HBsAg) seropositivity, anti-HCV seropositivity, platelet count, serum biochemical data, blood pressure, sociodemographic information, and anthropometric measurements were analyzed. Survival analyses were used to identify the associations between these factors and HCC. For the 262 HCC cases, male gender and age greater than 65 years were risk factors. Furthermore, a high alanine aminotransferase level, chronic HBV and/or HCV infection, and liver cirrhosis were also risk factors for HCC. However, DM, MetS and obesity were not associated with HCC development in the non-HBV-/non-HCV-infected, HBV, HCV, or dual B/C groups. In this HBV- and HCV- endemic area, DM, MetS and obesity were not risk factors for developing HCC.
Copyright © 2013. Published by Elsevier B.V.

Entities:  

Keywords:  Diabetes mellitus; Hepatocellular carcinoma; Metabolic syndrome; Obesity

Mesh:

Year:  2013        PMID: 23906236     DOI: 10.1016/j.kjms.2012.12.006

Source DB:  PubMed          Journal:  Kaohsiung J Med Sci        ISSN: 1607-551X            Impact factor:   2.744


  18 in total

1.  Time trends of clinical characteristics in hepatocellular carcinoma patients with chronic hepatitis B virus infection: A field survey between 2000 and 2012.

Authors:  Keisuke Amano; Takumi Kawaguchi; Ryoko Kuromatsu; Atsushi Kawaguchi; Ichiro Miyajima; Tatsuya Ide; Tatsuyuki Kakuma; Michio Sata
Journal:  Mol Clin Oncol       Date:  2014-08-21

2.  Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis.

Authors:  Ju Dong Yang; Hager Amed Mohamed; Jessica L Cvinar; Gregory J Gores; Lewis R Roberts; W Ray Kim
Journal:  Am J Gastroenterol       Date:  2016-08-16       Impact factor: 10.864

Review 3.  Could metabolic syndrome lead to hepatocarcinoma via non-alcoholic fatty liver disease?

Authors:  Antonella Scalera; Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

4.  Comparison Stratagems of Post-Screening Management of Anti-HCV-Positive Community Residents: Simple Notification, Active Referral, or Accessible Medical Care.

Authors:  Yuan-Hung Kuo; Pao-Fei Chen; Jing-Houng Wang; Kuo-Chin Chang; Kwong-Ming Kee; Ming-Chao Tsai; Chun-Yin Lin; Sheng-Che Lin; Lin-San Tsai; Shu-Chuan Chen; Sheng-Nan Lu
Journal:  PLoS One       Date:  2015-05-13       Impact factor: 3.240

5.  Associated Factors for Metabolic Syndrome in the Older Adults with Chronic Virus Hepatitis in the Community.

Authors:  Yuan-Hung Kuo; Ming-Chao Tsai; Kwong-Ming Kee; Kuo-Chin Chang; Jing-Houng Wang; Chun-Yin Lin; Sheng-Che Lin; Sheng-Nan Lu
Journal:  PLoS One       Date:  2016-05-13       Impact factor: 3.240

6.  Association Between Hepatocellular Carcinoma and Type 2 Diabetes Mellitus in Chinese Hepatitis B Virus Cirrhosis Patients: A Case-Control Study.

Authors:  Huixian Han; Han Deng; Tao Han; Haitao Zhao; Feifei Hou; Xingshun Qi
Journal:  Med Sci Monit       Date:  2017-07-09

Review 7.  Should adults with diabetes mellitus be vaccinated against hepatitis B virus? A systematic review of diabetes mellitus and the progression of hepatitis B disease.

Authors:  Zobair Younossi; Katrin Kochems; Marc de Ridder; Desmond Curran; Eveline M Bunge; Laurence de Moerlooze
Journal:  Hum Vaccin Immunother       Date:  2017-07-25       Impact factor: 3.452

8.  Influence of Metabolic Syndrome on Cancer Risk in HBV Carriers: A Nationwide Population Based Study Using the National Health Insurance Service Database.

Authors:  Jung Wan Choe; Jong Jin Hyun; Bongseong Kim; Kyung-Do Han
Journal:  J Clin Med       Date:  2021-05-29       Impact factor: 4.241

9.  Non-alcoholic steatohepatitis-related liver cirrhosis is increasing in China: a ten-year retrospective study.

Authors:  Ji Xiong; Jun Wang; Juan Huang; Wenjing Sun; Jun Wang; Dongfeng Chen
Journal:  Clinics (Sao Paulo)       Date:  2015-08       Impact factor: 2.365

Review 10.  Diabetes Mellitus and Risk of Hepatocellular Carcinoma.

Authors:  Xu Li; Xiaocong Wang; Pujun Gao
Journal:  Biomed Res Int       Date:  2017-12-12       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.